QQQ   303.20 (-0.09%)
AAPL   123.07 (+0.29%)
MSFT   214.45 (-0.81%)
FB   287.80 (+0.44%)
GOOGL   1,827.00 (+1.76%)
AMZN   3,206.72 (-0.41%)
TSLA   560.27 (-4.19%)
NVDA   541.78 (+1.15%)
BABA   261.58 (-0.92%)
CGC   28.39 (+6.53%)
GE   10.35 (+1.97%)
MU   68.75 (+2.49%)
AMD   93.59 (+1.04%)
T   28.94 (+0.24%)
NIO   47.57 (+4.87%)
F   9.17 (-0.76%)
ACB   10.99 (+12.72%)
NFLX   503.01 (-0.31%)
BA   221.32 (+3.90%)
GILD   61.16 (+0.07%)
DIS   152.41 (+1.99%)
QQQ   303.20 (-0.09%)
AAPL   123.07 (+0.29%)
MSFT   214.45 (-0.81%)
FB   287.80 (+0.44%)
GOOGL   1,827.00 (+1.76%)
AMZN   3,206.72 (-0.41%)
TSLA   560.27 (-4.19%)
NVDA   541.78 (+1.15%)
BABA   261.58 (-0.92%)
CGC   28.39 (+6.53%)
GE   10.35 (+1.97%)
MU   68.75 (+2.49%)
AMD   93.59 (+1.04%)
T   28.94 (+0.24%)
NIO   47.57 (+4.87%)
F   9.17 (-0.76%)
ACB   10.99 (+12.72%)
NFLX   503.01 (-0.31%)
BA   221.32 (+3.90%)
GILD   61.16 (+0.07%)
DIS   152.41 (+1.99%)
QQQ   303.20 (-0.09%)
AAPL   123.07 (+0.29%)
MSFT   214.45 (-0.81%)
FB   287.80 (+0.44%)
GOOGL   1,827.00 (+1.76%)
AMZN   3,206.72 (-0.41%)
TSLA   560.27 (-4.19%)
NVDA   541.78 (+1.15%)
BABA   261.58 (-0.92%)
CGC   28.39 (+6.53%)
GE   10.35 (+1.97%)
MU   68.75 (+2.49%)
AMD   93.59 (+1.04%)
T   28.94 (+0.24%)
NIO   47.57 (+4.87%)
F   9.17 (-0.76%)
ACB   10.99 (+12.72%)
NFLX   503.01 (-0.31%)
BA   221.32 (+3.90%)
GILD   61.16 (+0.07%)
DIS   152.41 (+1.99%)
QQQ   303.20 (-0.09%)
AAPL   123.07 (+0.29%)
MSFT   214.45 (-0.81%)
FB   287.80 (+0.44%)
GOOGL   1,827.00 (+1.76%)
AMZN   3,206.72 (-0.41%)
TSLA   560.27 (-4.19%)
NVDA   541.78 (+1.15%)
BABA   261.58 (-0.92%)
CGC   28.39 (+6.53%)
GE   10.35 (+1.97%)
MU   68.75 (+2.49%)
AMD   93.59 (+1.04%)
T   28.94 (+0.24%)
NIO   47.57 (+4.87%)
F   9.17 (-0.76%)
ACB   10.99 (+12.72%)
NFLX   503.01 (-0.31%)
BA   221.32 (+3.90%)
GILD   61.16 (+0.07%)
DIS   152.41 (+1.99%)
Log in
ARCA:ARMP

Armata Pharmaceuticals Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average Volume21,013 shs
Market Capitalization$58.54 million
P/E RatioN/A
Dividend YieldN/A
Beta1.9
Armata Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for the treatment of antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates includes AP-SA02, which is in Phase 1b/2 clinical trial and AP-SA01 that targets staphylococcus aureus, including multidrug-resistant strains. It is also developing and advancing AP-PA02 that is in Phase 1b/2 clinical trial for treating diseases caused by pseudomonas aeruginosa. The company is headquartered in Marina del Rey, California.

Beat the Market (BTM) Rank™

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

0.46 out of 5 stars


Industry, Sector and Symbol

Stock Exchange ARCA
Industry Biological products, except diagnostic
Sub-IndustryN/A
SectorMedical
Current SymbolARCA:ARMP
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.armatapharma.com
Phone858 829 0829
Employees33

Debt

Debt-to-Equity RatioN/A
Current Ratio2.41
Quick Ratio2.41

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$120,000.00
Price / Sales0.00
Cash FlowN/A
Price / Cash FlowN/A
Book Value$1.32 per share
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)($2.55)
Net Income$-19,480,000.00
Net MarginsN/A
Return on Equity-78.74%
Return on Assets-48.92%

Miscellaneous

Outstanding Shares18,700,000
Market Cap$58.54 million
Next Earnings DateN/A
OptionableNot Optionable
30 days | 90 days | 365 days | Advanced Chart

Receive ARMP News and Ratings via Email

Sign-up to receive the latest news and ratings for ARMP and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Armata Pharmaceuticals (ARCA:ARMP) Frequently Asked Questions

What stocks does MarketBeat like better than Armata Pharmaceuticals?

Wall Street analysts have given Armata Pharmaceuticals a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Armata Pharmaceuticals wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of Armata Pharmaceuticals' key competitors?

Some companies that are related to Armata Pharmaceuticals include Lineage Cell Therapeutics (LCTX), LogicBio Therapeutics (LOGC), Genfit (GNFT), Solid Biosciences (SLDB), Fennec Pharmaceuticals (FENC), Axcella Health (AXLA), ADMA Biologics (ADMA), ERYTECH Pharma (ERYP), Brainstorm Cell Therapeutics (BCLI), Dyadic International (DYAI), Gamida Cell (GMDA), Lineage Cell Therapeutics (LCTX), Idera Pharmaceuticals (IDRA), Outlook Therapeutics (OTLK) and Aziyo Biologics (AZYO).
View all competitors.

Who are Armata Pharmaceuticals' key executives?

Armata Pharmaceuticals' management team includes the following people:
  • Mr. Todd R. Patrick, CEO & Director (Age 57, Pay $556.2k)
  • Dr. Brian Varnum, Pres & Chief Devel. Officer (Age 60, Pay $409.6k)
  • Mr. Steven R. Martin, Sr. VP & CFO (Age 59, Pay $409.6k)
  • Dr. Wenyuan Shi, Co-Founder & Founding Scientist
  • Mr. Duane Alfred Morris B.A., BA, VP of Operations (Age 70)

What is Armata Pharmaceuticals' stock symbol?

Armata Pharmaceuticals trades on the ARCA under the ticker symbol "ARMP."

How do I buy shares of Armata Pharmaceuticals?

Shares of ARMP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

How big of a company is Armata Pharmaceuticals?

Armata Pharmaceuticals has a market capitalization of $0.00 and generates $120,000.00 in revenue each year. The company earns $-19,480,000.00 in net income (profit) each year or ($2.55) on an earnings per share basis. Armata Pharmaceuticals employs 33 workers across the globe.

What is Armata Pharmaceuticals' official website?

The official website for Armata Pharmaceuticals is www.armatapharma.com.

How can I contact Armata Pharmaceuticals?

Armata Pharmaceuticals' mailing address is 4503 GLENCOE AVENUE, MARINA DEL REY CA, 90292. The company can be reached via phone at 858 829 0829 or via email at [email protected]

This page was last updated on 12/2/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.